Protalix Biotherapeutics Inc (PLX) is a biotechnology company listed on US.
Latest reported PLX revenue for 2026-06-30 was $53.6M. Net income was $22.1M. Revenue was up 59.0% from 2026-03-31 to 2026-06-30. PLX currently screens at market cap $122.6M and trailing P/E 30.8.
Use this PLX page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the PLX quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the PLX SEC filings page. Lician reads the product cache first so this HTML stays unique to Protalix Biotherapeutics Inc even when a live quote feed is slow.
Latest cached year on this hub. Full PLX income, balance, and cash tables.